Verb Biotics announces acquisition of YSOPIA Bioscience health and wellness strains
2023-06-13
并购微生物疗法
Verb Biotics acquires YSOPIA Bioscience's strain library and IP assets.
BOSTON, June 13, 2023 /PRNewswire/ -- Verb Biotics LLC., a microbiome innovation company, today announced that they have acquired YSOPIA Bioscience's strain and IP portfolio targeted for human health and wellness.
The acquisition of YSOPIA's strain portfolio includes one of the most comprehensive and well characterized libraries of Christensenella minuta available, the associated IP, and other unique bacterial strains. "This acquisition will further our strategy; delivering breakthrough microbiome solutions that have specific mechanisms of action for targeted health outcomes such as gut-brain axis health, healthy aging, sports recovery, and metabolic support," said Todd Beckman, Verb's CEO.
As a keystone bacterium, Christensenella minuta plays a major role in the development of a healthy gut microbiome. In observational and association studies, Christensenella has demonstrated an important role in regulating energy balance and metabolic homeostasis. The strain is an emerging technology that restores gut health through regulating inflammation. "We're excited to leverage our advanced technology platform to bring the next generation of breakthrough strains to the widest audience and look forward to building upon the great science that was started at YSOPIA," stated Camille Delebecque, Verb's Head of Biotechnology.
Verb Biotics will incorporate the YSOPIA strain portfolio into their product library and plan to have a commercial offering in the next 18-24 months for food, beverage, and supplement brands. "Brands are asking for innovation. By delivering these next generation strains we are expanding our breadth of function-first solutions," said Peggy Steele, Chief Commercial Officer at Verb.
For more information about how Verb Biotics improves human health through microbiome innovation, please visit verbbiotics.com.
About Verb Biotics
From discovery to scale, Verb Biotics applies science, technology, and intentional development to deliver microbiome health solutions. Verb Biotics is a business-to-business ingredient supplier of pro, post and synbiotics for food, beverage and dietary supplement brands. Please visit www.verbbiotics.com for more information.
SOURCE Verb Biotics
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。